BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11874523)

  • 1. Serum pharmacokinetics and tissue and milk residues of oxytetracycline in goats following a single intramuscular injection of a long-acting preparation and milk residues following a single subcutaneous injection.
    Payne MA; Babish JG; Bulgin M; Lane M; Wetzlich S; Craigmill AL
    J Vet Pharmacol Ther; 2002 Feb; 25(1):25-32. PubMed ID: 11874523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and residues in milk of oxytetracyclines administered parenterally to dairy goats.
    Rule R; Moreno L; Serrano JM; Roman AG; Moyano R; Garcia J
    Aust Vet J; 2001 Jul; 79(7):492-6. PubMed ID: 11549049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum pharmacokinetics of oxytetracycline in sheep and calves and tissue residues in sheep following a single intramuscular injection of a long-acting preparation.
    Craigmill AL; Holland RE; Robinson D; Wetzlich S; Arndt T
    J Vet Pharmacol Ther; 2000 Dec; 23(6):345-52. PubMed ID: 11168911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of a long-acting formulation of oxytetracycline in sheep and goats.
    Escudero E; Carceles CM; Ponferrada C; Baggot JD
    J Vet Pharmacol Ther; 1996 Feb; 19(1):75-7. PubMed ID: 8992031
    [No Abstract]   [Full Text] [Related]  

  • 5. Some pharmacokinetic parameters and dosage regimens for a long-acting formulation of oxytetracycline in 6- to 8-month-old male calves.
    Kumar R; Malik JK
    Vet Res Commun; 1998 Dec; 22(8):533-44. PubMed ID: 10066127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of oxytetracycline into the nasal secretions and relationship between nasal secretions and plasma oxytetracycline concentrations after oral and intramuscular administration in healthy pigs.
    Bimazubute M; Cambier C; Baert K; Vanbelle S; Chiap P; Gustin P
    J Vet Pharmacol Ther; 2011 Apr; 34(2):176-83. PubMed ID: 21395609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of theophylline on serum and milk pharmacokinetics of tylosin following intramuscular administration in lactating goats.
    El-Tareef FS; Abo-El-Sooud K; Karmi M; Hafez A
    BMC Vet Res; 2024 Jun; 20(1):251. PubMed ID: 38849822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of oxytetracycline in goats: modifications induced by a long-acting formulation.
    Escudero E; Carceles CM; Serrano JM
    Vet Rec; 1994 Dec; 135(23):548-52. PubMed ID: 7886888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and residual behaviour in milk of oxytetracycline in cows following administration of uterine pessaries.
    Roncada P; Ermini L; Schleuning A; Stracciari GL; Strocchia A
    J Vet Pharmacol Ther; 2000 Oct; 23(5):281-5. PubMed ID: 11107001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short communication: Determination of withdrawal time for oxytetracycline in different types of goats for milk consumption.
    Attaie R; Bsharat M; Mora-Gutierrez A; Woldesenbet S
    J Dairy Sci; 2015 Jul; 98(7):4370-6. PubMed ID: 25958275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle tissue kinetics of oxytetracycline following intramuscular and oral administration at two dosages to giant freshwater shrimp (Macrobrachium rosenbergii).
    Poapolathep A; Poapolathep S; Jermnak U; Imsilp K; Wannapat N; Sugita-Konishi Y; Kumagai S
    J Vet Pharmacol Ther; 2008 Dec; 31(6):517-22. PubMed ID: 19000273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of a long-acting oxytetracycline formulation in Thai swamp buffaloes (Bubalus bubalis).
    Poapolathep S; Wongpanit K; Imsilp K; Tanhan P; Klangkaew N; Giorgi M; Poapolathep A
    J Vet Pharmacol Ther; 2017 Apr; 40(2):206-209. PubMed ID: 27597645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the pharmacokinetics and local tolerance of three injectable oxytetracycline formulations in pigs.
    Banting AL; Baggot JD
    J Vet Pharmacol Ther; 1996 Feb; 19(1):50-5. PubMed ID: 8992026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and tissue residues of an oxytetracycline/diclofenac combination in cattle.
    Mestorino N; Mariño Hernández E; Marchetti L; Errecalde JO
    Rev Sci Tech; 2007 Dec; 26(3):679-90. PubMed ID: 18293616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A physiologically based pharmacokinetic model for oxytetracycline residues in sheep.
    Craigmill AL
    J Vet Pharmacol Ther; 2003 Feb; 26(1):55-63. PubMed ID: 12603776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma pharmacokinetics and milk residues of flunixin and 5-hydroxy flunixin following different routes of administration in dairy cattle.
    Kissell LW; Smith GW; Leavens TL; Baynes RE; Wu H; Riviere JE
    J Dairy Sci; 2012 Dec; 95(12):7151-7. PubMed ID: 23040013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic disposition of a long-acting oxytetracycline formulation after single-dose intravenous and intramuscular administrations in the American alligator (Alligator mississippiensis).
    Helmick KE; Papich MG; Vliet KA; Bennett RA; Jacobson ER
    J Zoo Wildl Med; 2004 Sep; 35(3):341-6. PubMed ID: 15526889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential for oxytetracycline administration by three routes to cause milk residues in lactating cows, as detected by radioimmunoassay (Charm II) and high-performance liquid chromatography test methods.
    Anderson KL; Moats WA; Rushing JE; Wesen DP; Papich MG
    Am J Vet Res; 1995 Jan; 56(1):70-7. PubMed ID: 7695153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel delivery of oxytetracycline in turkey breeder hens.
    Carver DK; Grimes JL; Christensen VL; Joyce KA; Fairchild BD; Fairchild AS
    Avian Dis; 2001; 45(2):437-41. PubMed ID: 11417824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cefonicid in lactating goats after intravenous, intramuscular and subcutaneous administration, and after a long-acting formulation for subcutaneous administration.
    Badillo E; Escudero E; Hernandis V; Galecio JS; Marín P
    J Vet Pharmacol Ther; 2020 Jan; 43(1):50-56. PubMed ID: 31724779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.